Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

8 Nov 2016 07:00

RNS Number : 5525O
Craneware plc
08 November 2016
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2016 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We continue to see positive results in the first few months of the current fiscal year. In September we announced the move back into double-digit revenue and adjusted EBITDA growth. With the impact of sales made during FY16 starting to contribute to revenue, combined with our sales pipeline and activity, we see that momentum continuing in the current year.

 

"The US healthcare market continues its evolution towards value-based care with a critical dependency on accurate financial and operating data. We are investing in our Value Cycle product suite to ensure we have the solutions to provide hospitals with tools that deliver insight into these areas of their operations, expanding our market opportunity and increasing our strategic value within our market.

 

"2017 will see some exciting developments for Craneware with the launch of Trisus Claims Informatics, the first product to be launched on our newly developed cloud-based Trisus Enterprise Value Platform; followed shortly thereafter by the launch of Trisus Patient Payment, a new fourth gateway product, operating within the patient access and engagement area.

 

"We are also making good progress within our newly formed Group business, Craneware Healthcare Intelligence, which is focused on the development of cost analytics software for the US healthcare industry.

 

"With our expanded offering and market opportunity, high levels of revenue visibility and favourable market backdrop, we believe we are just at the start of a long-term growth trajectory and are confident in the future success of Craneware."

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

 

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

 

Keith Neilson, CEO

Dan Webster

Caroline Forde

 

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

 

 

George Sellar

Robyn McConnachie

 

 

 

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDGBDBRUGBGLR
Date   Source Headline
20th May 202511:27 amRNSForm 8.5 (EPT/NON-RI)-Craneware plc
20th May 202511:09 amRNSForm 8.5 (EPT/RI)-Craneware plc
20th May 20259:59 amRNSForm 8.5 (EPT/RI) - Craneware PLC
20th May 20259:29 amRNSForm 8.3 - Craneware PLC
19th May 20254:23 pmRNSForm 8.5 (EPT/NON-RI)-Craneware plc
19th May 20254:02 pmRNSForm 8.3 - Craneware plc
19th May 20253:20 pmRNSForm 8.3 - Craneware plc
19th May 20253:16 pmRNSForm 8.3 - CRANEWARE PLC
19th May 20252:29 pmGNWForm 8.3 - Craneware Plc
19th May 20252:08 pmBUSForm 8.3 - Craneware PLC
19th May 20251:45 pmGNWForm 8.3 - Craneware plc - Octopus Investments
19th May 20251:43 pmRNSForm 8.3 - Craneware Plc
19th May 20251:42 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGAML)
19th May 20251:38 pmGNWForm 8.3 - [CRANEWARE PLC - 16 05 2025] - (CGWL)
19th May 202512:50 pmRNSForm 8.3 - Craneware PLC
19th May 202512:11 pmBUSForm 8.3 - Craneware plc
19th May 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc
19th May 202511:55 amRNSForm 8.3 - Craneware plc
19th May 202511:15 amRNSForm 8.5 (EPT/RI)-Craneware plc
19th May 202511:09 amRNSForm 8.5 (EPT/RI) - CRANEWARE PLC
19th May 202510:31 amRNSForm 8.5 (EPT/RI) - Craneware plc
19th May 20258:57 amGNWForm 8.5 (EPT/RI)-Craneware plc
16th May 20253:16 pmRNSResponse to Statement by Bain Capital
16th May 20251:16 pmRNSForm 8.3 - CRANEWARE PLC
16th May 20259:41 amRNSStatement re Possible Offer
1st May 20253:52 pmRNSHolding(s) in Company
28th Apr 20257:00 amRNSPurchase of Shares by Director and TVR
15th Apr 20257:00 amRNSBlock listing Interim Review
21st Mar 20251:50 pmRNSDividend Currency Election
11th Mar 20257:00 amRNSFY25 Interim Results
19th Feb 20253:23 pmRNSNotification of major holdings
13th Jan 20257:00 amRNSH1 FY25 Trading Update
29th Nov 20244:18 pmRNSDividend Currency Election
20th Nov 20241:57 pmRNSHolding(s) in Company
19th Nov 20245:13 pmRNSVesting of Long Term Incentive Plan Awards and TVR
13th Nov 20241:23 pmRNSResult of AGM
13th Nov 20247:00 amRNSAGM Statement and Board Changes
25th Oct 20243:02 pmRNSHolding(s) in Company
16th Oct 20245:05 pmRNSPosting of Annual Report and Notice of AGM
15th Oct 20247:00 amRNSBlock listing Interim Review
2nd Oct 202412:30 pmRNSTotal Voting Rights
23rd Sep 20245:31 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSExercise of Share Options
17th Sep 20244:40 pmRNSGrant of Long Term Incentive Plan Awards
12th Sep 20244:50 pmRNSNotification of Major Holdings
11th Sep 20243:45 pmRNSDirector/PDMR Dealings
10th Sep 20247:00 amRNSRelease and discharge of security in the Company
3rd Sep 20247:00 amRNSFY24 Final Results
27th Aug 20247:00 amRNSNotice of Results Presentations
18th Jul 20247:00 amRNSFY24 Trading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.